Pure C15:0: A Small Fatty Acid With an Emerging Role in Healthy Aging

Not every saturated fat behaves in the same biological way.

C15:0, also known as pentadecanoic acid, is an odd-chain saturated fatty acid found naturally in small amounts in dairy fat and certain fish. It is now being studied for its potential role in cell-membrane structure, metabolic signalling and long-term physiological resilience.

The science is promising, but it is still emerging. C15:0 should not be presented as a treatment for cancer, diabetes, liver disease, cardiovascular disease or any other medical condition. Associations and laboratory findings are not the same as proven clinical outcomes.

What makes C15:0 scientifically interesting is its structural role. Cell membranes are not passive barriers. They influence how cells communicate, respond to stress and maintain stability. C15:0 is incorporated into lipid structures and may contribute to membrane integrity and signalling pathways relevant to metabolic health.

What does the evidence currently suggest?

Higher circulating C15:0 levels have been associated in observational research with more favourable cardiometabolic and liver-health markers. Laboratory and early translational studies have also explored possible effects on inflammatory signalling, mitochondrial function and metabolic pathways such as AMPK and mTOR.

These findings are relevant to longevity research because cellular resilience, inflammation control and metabolic flexibility are central themes in healthy aging.

However, associations do not prove that supplementation prevents disease or extends lifespan. High-quality, independent, long-term human trials remain necessary.

A measured approach to dosing

For pure C15:0, dose discipline matters.

Hansen Supplements specifies that its C15:0 product contains 99%+ pure pentadecanoic acid and recommends a daily intake of up to 0.3 g, or 300 mg, daily. The product is supplied with a dedicated measuring spoon intended to support accurate dosing.

From a clinical perspective, a sensible approach is:

• Start with 100 mg daily with a meal
• Review tolerance over one to two weeks
• Increase only where appropriate, without exceeding 300 mg daily unless specifically advised by a physician

C15:0 is not a replacement for dietary quality. A longevity-oriented nutrition plan should still prioritise adequate protein, fibre, vegetables, legumes, healthy fats, micronutrients and metabolic health markers.

Who should speak with a physician first?

Anyone who is pregnant or breastfeeding, undergoing cancer treatment, living with liver disease, managing diabetes, taking lipid-lowering treatment, or using multiple medications should speak with a physician before introducing C15:0.

This is especially important because C15:0 research is evolving and because an individual longevity protocol should be based on the person's full metabolic profile, laboratory data, medication list and health priorities.

My clinical perspective

C15:0 is one of the more interesting emerging nutrients in longevity science because it sits at the intersection of nutrition, membrane biology and metabolic signalling.

I view it as a potential foundational tool, not a miracle molecule. The strongest protocol remains the one that is measured, personalised and clinically monitored.

Complimentary visitor resource: Download our Longevity Supplement Decision Framework to assess whether a supplement has a clear purpose, appropriate dose, relevant monitoring plan and acceptable interaction profile before adding it to your routine.

This article is educational and does not replace individual medical advice, diagnosis or treatment.